Key factors
sym | KBLM |
exch | US |
MCap | 85.84M |
Beta | -0.02 |
PE Ratio | 131.37 |
EPS | 0.08 |
Div date | 0000-00-00 |
Yesterday
sym | KBLM |
exch | US |
close | 195.0 |
50 Day MA | 10.46 |
200 Day MA | 10.36 |
52 Week High | 10.55 |
52 Week Low | 9.17 |
Market Cap Mln | 85.84 |
Share statistics
Shares Outstanding | 9748.98K |
Shares Float | 2753.52K |
Percent Institutions | 0.87 |
PercentInsiders | 0.33 |
SharesShort | 110.0 |
Short Ratio | 0.06 |
Shares Short Prior Month | 385.0 |
Income
Diluted Eps TTM | 0.08 |
Quarterly Earnings Growth YOY | 100.0 |
earning
Trailing PE | 131.37 |
Earnings Share | 0.08 |
Dividend
Dividend Date | 0000-00-00 |
Last Split Date | 0000-00-00 |
business
Book Value /share | 1.183 |
Price Book MRQ | 8.884 |
ReturnOnAssetsTTM | -0.00 |
ReturnOnEquityTTM | 0.219 |
Sector
Industry | Conglomerates |
Sector | Industrials |
Codes
CIK | 0001690080 |
Code | KBLM |
CUSIP | 48242A104 |
Employer Id Number | 81-3832378 |
CountryISO | US |
Currency Code | USD |
Currency Name | US Dollar |
Exchange | NASDAQ |
Currency Symbol | $ |
fund
Type | Common Stock |
UpdatedAt | 2019-08-01 |
info
Fiscal Year End | December |
IPODate | 2017 |
International Domestic | Domestic |
MostRecent Quarter | 2019-03-31 |
Contact
Name | KBL Merger Corp. IV |
Address | 527 Stanton Christiana Road 19713,Newark,USA |
Country Name | USA |
Phone | 302-502-2727 |
Web URL | www.kblmerger.com |
KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.